Headlines about Taro Pharmaceutical Industries (NYSE:TARO) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Taro Pharmaceutical Industries earned a news impact score of 0.24 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.0666063863995 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Separately, BidaskClub cut shares of Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a report on Thursday, October 12th.
Taro Pharmaceutical Industries (NYSE:TARO) traded up $0.67 during mid-day trading on Monday, reaching $105.77. 46,100 shares of the company’s stock were exchanged, compared to its average volume of 76,456. Taro Pharmaceutical Industries has a one year low of $94.00 and a one year high of $128.46. The company has a market capitalization of $4,241.59, a PE ratio of 13.03 and a beta of 0.63.
Taro Pharmaceutical Industries (NYSE:TARO) last released its earnings results on Tuesday, November 7th. The company reported $1.30 earnings per share for the quarter. Taro Pharmaceutical Industries had a net margin of 30.97% and a return on equity of 9.71%.
COPYRIGHT VIOLATION WARNING: “Taro Pharmaceutical Industries (TARO) Earns News Impact Score of 0.24” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://ledgergazette.com/2018/01/15/taro-pharmaceutical-industries-taro-getting-somewhat-positive-media-coverage-report-finds.html.
Taro Pharmaceutical Industries Company Profile
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.